Sign inJoin waitlistJoin the waitlist

David Iberri

Hematology · Stanford Health Care

Credentials: · · ·

History

Stanford University
Until 2015
Stanford University
Until 2013
Stanford University
Until 2011
University of Vermont College of Medicine
2010

Research

Postibrutinib outcomes in patients with mantle cell lymphoma
Blood · 2016 · 259 citations
Wikipedia: a key tool for global public health promotion
Journal of Medical Internet Research · 2011 · 114 citations
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
American Journal of Hematology · 2019 · 66 citations

Michaela Liedtke
5 papers
David Miklos
4 papers
Sally Arai
4 papers
Surbhi Sidana
4 papers
Jean Oak
3 papers
Jonathan Chen
3 papers · 1 as a fellow
Lori Muffly
3 papers
Matthew Frank
3 papers
Parveen Shiraz
3 papers
Ranjana Advani
3 papers
Rondeep Brar
3 papers
Wen-Kai Weng
3 papers

Clinical trials

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 1
Stanford University
2014–2015
Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 2
David Iberri
2013–2016
Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant
Principal investigator · Withdrawn · Phase 2
Stanford University
2018